Manz ML nudges (long-term)
2023
Long-term Effect of Machine Learning-Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer
In 20,506 patients with cancer, machine-learning-triggered behavioural nudges to clinicians over 40 weeks increased serious illness conversations and reduced end-of-life systemic therapy compared with usual care.
Result
Efficacy: Serious illness conversation rates for all and high-risk patient encounters; secondary end-of-life outcomes among decedentsaOR 2.09 (95% CI 1.53-2.87) · P < 0.001
Below 1 favours usual care, above 1 favours machine-learning-triggered behavioural nudges to clinicians over 40 weeks.
The estimate refers to a different reading of the endpoint than the rates.
Also reported: End-of-life systemic therapy 7.5% vs 10.4% (aOR 0.25, 95% CI 0.11–0.57; P=0.001); no effect on hospice enrolment or length of stay, inpatient death or end-of-life ICU use.
- Subtopic
- Prognostic nudges
- Design
- Stepped-wedge cluster RCT, prespecified 40-week analysis, 9 oncology clinics
- Relevance
- Important: one of several pillars.
- Source
- Manz CR, et al. JAMA Oncol. 2023;9(3):414-418.doi 10.1001/jamaoncol.2022.6303
Discussion & critique
Extends the 2020 stepped-wedge trial (Manz ML nudges (SIC)) to 40 weeks and to what matters at the end of life: the conversation gain persisted and systemic therapy near death fell, a patient-level end-of-life outcome, not just a process measure. Hospice, ICU and inpatient-death outcomes were unchanged, only 1,417 patients (6.9%) had died by the end of follow-up, and the single-system setting limits generalisability.